| Peer-Reviewed

Mass Spectrometry Analysis of Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives

Received: 26 October 2015     Accepted: 26 November 2015     Published: 22 December 2015
Views:       Downloads:
Abstract

2-Aminopyridine (2-AP) and 2,6-diaminopyridine (2,6-DAP) are two derivatives of aminopyridines that act as an important organic intermediates, mostly used in medicines, dyes and organic sensors. The aim of the study was to evaluate the impact of biofield energy treatment on isotopic abundance ratios of 2H/1H, 13C/12C, or 15N/14N, in aminopyridine derivatives using gas chromatography-mass spectrometry (GC-MS). The 2-AP and 2,6-DAP samples were divided into two parts: control and treated. The control sample remained as untreated, while the treated sample was further divided into four groups as T1, T2, T3, and T4. The treated group was subjected to Mr. Trivedi’s biofield energy treatment. The GC-MS spectra of 2-AP and 2,6-DAP showed five and six m/z peaks respectively due to the molecular ion peak and fragmented peaks of aminopyridine derivatives. The isotopic abundance ratio of 2H/1H, 13C/12C, or 15N/14N were calculated for both the derivatives and significant alteration was found in the treated samples as compared to the respective control. The isotopic abundance ratio of 2H/1H, 13C/12C, or 15N/14N in treated samples of 2-AP was decreased by 55.83% in T1 and significantly increased by 202.26% in T4. However, in case of 2,6-DAP, the isotopic abundance ratio of 2H/1H, 13C/12C, and 15N/14N, in the treated sample showed a significant increase (up to 370.54% in T3) with respect to the control. GC-MS data suggested that the biofield energy treatment on aminopyridine derivatives had significantly altered the isotopic abundance of 2H, 13C, or 15N in the treated 2-AP and 2,6-DAP as compared to the control.

Published in American Journal of Physical Chemistry (Volume 4, Issue 6)
DOI 10.11648/j.ajpc.20150406.14
Page(s) 65-70
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2015. Published by Science Publishing Group

Keywords

Biofield Energy Treatment, 2-Aminopyridine, 2,6-Diaminopyridine, Gas Chromatography-Mass Spectrometry

References
[1] Muccio Z, Jackson GP (2009) Isotope ratio mass spectrometry. Analyst 134: 213-222.
[2] Rieley G (1994) Derivatization of organic-compounds prior to gas-chromatographic combustion-isotope ratio mass-spectrometric analysis: Identification of isotope fractionation processes. Analyst 119: 915-919.
[3] Weisel CP, Park S, Pyo H, Mohan K, Witz G (2003) Use of stable isotopically labeled benzene to evaluate environmental exposures. J Expo Anal Environ Epidemiol 13: 393-402.
[4] Hoefs J (2009) Stable Isotope Geochemistry, Isotope Fractionation Processes of Selected Elements. Springer-Verlag Berlin Heidelberg.
[5] May BCH, Zorn JA, Witkop J, Sherrill J, Wallace AC, et. al (2007) Structure-activity relationship study of prion inhibition by 2-aminopyridine-3, 5-dicarbonitrile-based compounds: Parallel synthesis, bioactivity, and in vitro pharmacokinetics. J Med Chem 50:65-73.
[6] Coleman MD (2010) Human Drug Metabolism. Role of Metabolism in Drug Toxicity. John Wiley & Sons, Ltd.; New York.
[7] Araki Y, Andoh A, Fujiyama Y, Hata K, Makino J (2001) Application of 2-aminopyridine fluorescence labeling in the analysis of in vivo and in vitro metabolism of dextran sulfate sodium by size-exclusion high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 753: 209-215.
[8] Korenke AR, Rivey MP, Allington DR (2008) Sustained-release fampridine for symptomatic treatment of multiple sclerosis. Ann Pharmacother 42: 1458-1465.
[9] New Drugs: Fampridine. (2011) Australian Prescriber (34): 119-123.
[10] Gonzalez Cabrera D, Douelle F, Younis Y, Feng TS, Le Manach C, et al. (2012) Structure activity relationship studies of orally active antimalarial 3, 5- substituted 2-aminopyridines. J Med Chem 55: 11022-11030.
[11] Naixing W, Boren C, Yuxiang O (1993) Synthesis of N-2,4,6-trinitrophenyl-N’- 2, 4, dinitrobenzofuroxano-3, 5-dinitro-, G-diaminopyridine. J Energ Mater 11: 47-50.
[12] Schwalbe CH, Williams GJB, Koetzle TF (1987) A neutron diffraction study of 2, 6-Diaminopyridine at 20K. Acta Cryst C 43: 2191-2195.
[13] Freeman HG, Gillern MF, Smith HA (1976) Rapid curing, hydrophilic resin compositions. US 3947425 A.
[14] Dickson SJ, Paterson MJ, Willans CE, Anderson KM, Steed JW (2008) Anion binding and luminescent sensing using cationic ruthenium(II) aminopyridine complexes. Chem Eur J 14: 7296-7305.
[15] Trivedi MK, Patil S, Tallapragada RM (2012) Thought intervention through bio field changing metal powder characteristics experiments on powder characteristics at a PM plant. Future Control and Automation LNEE 173: 247-252.
[16] Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) Antimicrobial sensitivity pattern of Pseudomonas fluorescens after biofield treatment. J Infect Dis Ther 3: 222.
[17] Patil S, Nayak GB, Barve SS, Tembe RP, Khan RR (2012) Impact of biofield treatment on growth and anatomical characteristics of Pogostemon cablin (Benth.). Biotechnology 11: 154-162.
[18] Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343: 1-19.
[19] http://webbook.nist.gov/cgi/cbook.cgi?ID=C504290&Mask=200#Mass-Spec.
[20] Smith BC (2011) Fundamentals of Fourier transform infrared spectroscopy, CRC Press, Taylor and Francis Group, Boka Raton, New York.
[21] http://webbook.nist.gov/cgi/cbook.cgi?ID=C141866&Mask=200#Mass-Spec
[22] Mook W, Vries J (2003-2004) Environmental isotopes in the hydrological cycle principles and applications. International atomic energy agency, Vienna, 1-271.
Cite This Article
  • APA Style

    Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Gunin Saikia, et al. (2015). Mass Spectrometry Analysis of Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives. American Journal of Physical Chemistry, 4(6), 65-70. https://doi.org/10.11648/j.ajpc.20150406.14

    Copy | Download

    ACS Style

    Mahendra Kumar Trivedi; Alice Branton; Dahryn Trivedi; Gopal Nayak; Gunin Saikia, et al. Mass Spectrometry Analysis of Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives. Am. J. Phys. Chem. 2015, 4(6), 65-70. doi: 10.11648/j.ajpc.20150406.14

    Copy | Download

    AMA Style

    Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Gunin Saikia, et al. Mass Spectrometry Analysis of Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives. Am J Phys Chem. 2015;4(6):65-70. doi: 10.11648/j.ajpc.20150406.14

    Copy | Download

  • @article{10.11648/j.ajpc.20150406.14,
      author = {Mahendra Kumar Trivedi and Alice Branton and Dahryn Trivedi and Gopal Nayak and Gunin Saikia and Snehasis Jana},
      title = {Mass Spectrometry Analysis of Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives},
      journal = {American Journal of Physical Chemistry},
      volume = {4},
      number = {6},
      pages = {65-70},
      doi = {10.11648/j.ajpc.20150406.14},
      url = {https://doi.org/10.11648/j.ajpc.20150406.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpc.20150406.14},
      abstract = {2-Aminopyridine (2-AP) and 2,6-diaminopyridine (2,6-DAP) are two derivatives of aminopyridines that act as an important organic intermediates, mostly used in medicines, dyes and organic sensors. The aim of the study was to evaluate the impact of biofield energy treatment on isotopic abundance ratios of 2H/1H, 13C/12C, or 15N/14N, in aminopyridine derivatives using gas chromatography-mass spectrometry (GC-MS). The 2-AP and 2,6-DAP samples were divided into two parts: control and treated. The control sample remained as untreated, while the treated sample was further divided into four groups as T1, T2, T3, and T4. The treated group was subjected to Mr. Trivedi’s biofield energy treatment. The GC-MS spectra of 2-AP and 2,6-DAP showed five and six m/z peaks respectively due to the molecular ion peak and fragmented peaks of aminopyridine derivatives. The isotopic abundance ratio of 2H/1H, 13C/12C, or 15N/14N were calculated for both the derivatives and significant alteration was found in the treated samples as compared to the respective control. The isotopic abundance ratio of 2H/1H, 13C/12C, or 15N/14N in treated samples of 2-AP was decreased by 55.83% in T1 and significantly increased by 202.26% in T4. However, in case of 2,6-DAP, the isotopic abundance ratio of 2H/1H, 13C/12C, and 15N/14N, in the treated sample showed a significant increase (up to 370.54% in T3) with respect to the control. GC-MS data suggested that the biofield energy treatment on aminopyridine derivatives had significantly altered the isotopic abundance of 2H, 13C, or 15N in the treated 2-AP and 2,6-DAP as compared to the control.},
     year = {2015}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Mass Spectrometry Analysis of Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives
    AU  - Mahendra Kumar Trivedi
    AU  - Alice Branton
    AU  - Dahryn Trivedi
    AU  - Gopal Nayak
    AU  - Gunin Saikia
    AU  - Snehasis Jana
    Y1  - 2015/12/22
    PY  - 2015
    N1  - https://doi.org/10.11648/j.ajpc.20150406.14
    DO  - 10.11648/j.ajpc.20150406.14
    T2  - American Journal of Physical Chemistry
    JF  - American Journal of Physical Chemistry
    JO  - American Journal of Physical Chemistry
    SP  - 65
    EP  - 70
    PB  - Science Publishing Group
    SN  - 2327-2449
    UR  - https://doi.org/10.11648/j.ajpc.20150406.14
    AB  - 2-Aminopyridine (2-AP) and 2,6-diaminopyridine (2,6-DAP) are two derivatives of aminopyridines that act as an important organic intermediates, mostly used in medicines, dyes and organic sensors. The aim of the study was to evaluate the impact of biofield energy treatment on isotopic abundance ratios of 2H/1H, 13C/12C, or 15N/14N, in aminopyridine derivatives using gas chromatography-mass spectrometry (GC-MS). The 2-AP and 2,6-DAP samples were divided into two parts: control and treated. The control sample remained as untreated, while the treated sample was further divided into four groups as T1, T2, T3, and T4. The treated group was subjected to Mr. Trivedi’s biofield energy treatment. The GC-MS spectra of 2-AP and 2,6-DAP showed five and six m/z peaks respectively due to the molecular ion peak and fragmented peaks of aminopyridine derivatives. The isotopic abundance ratio of 2H/1H, 13C/12C, or 15N/14N were calculated for both the derivatives and significant alteration was found in the treated samples as compared to the respective control. The isotopic abundance ratio of 2H/1H, 13C/12C, or 15N/14N in treated samples of 2-AP was decreased by 55.83% in T1 and significantly increased by 202.26% in T4. However, in case of 2,6-DAP, the isotopic abundance ratio of 2H/1H, 13C/12C, and 15N/14N, in the treated sample showed a significant increase (up to 370.54% in T3) with respect to the control. GC-MS data suggested that the biofield energy treatment on aminopyridine derivatives had significantly altered the isotopic abundance of 2H, 13C, or 15N in the treated 2-AP and 2,6-DAP as compared to the control.
    VL  - 4
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Trivedi Global Inc., Henderson, USA

  • Trivedi Global Inc., Henderson, USA

  • Trivedi Global Inc., Henderson, USA

  • Trivedi Global Inc., Henderson, USA

  • Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India

  • Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India

  • Sections